Somalogic Inc (SLGC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SLGC Annual Cash Flow →
The table below presents a historical view of Somalogic Inc's cash flow activity, supporting analysis of liquidity trends over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
9 Months
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Operating Activities
Income-81.13
Depreciation & amortization5.54
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.35
Provision For Loan Losses Expensed-0.38
Inventories Decrease /-Increase-6.46
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation15.49
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-1.90
Investment Income Interest-
Fair Value Adjustment Of Derivative Liabilities-
Increase Decrease In Contract With Customer Liability-1.10
Noncash Lease Expense1.70
Business Combination Contingent Consideration Arrangements Change In Amount Of Earn Out Liability-0.02
Cloud Computing Arrangement Expenditures-1.50
Income taxes0.52
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-3.23
Increase (Decrease) in Accounts Payable-5.46
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-9.87
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets1.42
Other Working Capital-1.91
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.72
Discontinued operations0.00
Net Cash flow from Operating Activities-90.65
Investing Activities
Capital Expenditures-3.19
Sale of Capital Items0.00
Short-term Investments Proceeds144.03
Payments to Acquire Available-for-sale Securities, Debt-171.11
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-30.27
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.42
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-2.84
Deferred Offering Costs Included In Accrued Offering Costs-
Proceeds From Business Combination Net Of Transaction Costs-
Proceeds From Paycheck Protection Program Loan-
Capital Expenditures Incurred But Not Yet Paid0.82
Right Of Use Asset Obtained In Exchange For Operating Lease Liability2.02
Issuance Of Common Stock For Services-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.42
Effect of exchange rate on cash flow-0.04
Discontinued operations0.00
Free Cash Flow-93.84
Total Cash Flow-120.53
4 historic quarters locked

Sign in to unlock the full Somalogic Inc cash flow history.

About Somalogic Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-23-037928

Figures are derived from filed reports and may be restated. Historical data is subject to revision.